'On consolidated basis

Quarter ended March 2025 compared with Quarter ended March 2024.

Net sales (including other operating income) of Laurus Labs has increased 19.49% to Rs 1720.3 crore.  Operating profit margin has jumped from 16.77% to 24.45%, leading to 74.17% rise in operating profit to Rs 420.60 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 43.81% to 39.48%.   Purchase of finished goods cost fell from 3.02% to 1.41%.   Employee cost decreased from 11.94% to 11.20%.   Other expenses fell from 23.34% to 21.39%.   

Other income rose 216.08% to Rs 58.57 crore.  PBIDT rose 84.28% to Rs 479.17 crore.  Provision for interest rose 11.68% to Rs 56.4 crore.  Loan funds rose to Rs 2,763.73 crore as of 31 March 2025 from Rs 2,577.40 crore as of 31 March 2024.  Inventories rose to Rs 1,936.54 crore as of 31 March 202...

• 

  (05-Feb-2025)

  Castrol India

  Expects EBITDA margin of 22%-25% for CY25
• 

  (10-Feb-2023)

  Deepak Nitrite

  Plans capex of about Rs 1500 crore for FY23 and FY24
• 

  (09-Feb-2023)

  Mayur Uniquoters

  Targets revenue of Rs 1000 crore in FY24
• 

  (31-Jan-2023)

  Tega industries

  Capex plan is US$ 30-32 million for next three years